ALLOB

Bone Therapeutics’ cell therapy hits goal in phase 1/2a, but manufacturing changes slow progress
Fierce Biotech
Fri, 09/14/18 - 10:55 am
Bone Therapeutics
cell therapy
ALLOB
clinical trials